NDAINTRAVENOUSSOLUTION
Approved
Aug 2015
Lifecycle
Peak
Competitive Pressure
30/100
Mechanism of Action
12.1 Mechanism of Action Cefazolin is an antibacterial drug [ see ]. 12.2 Pharmacodynamics The pharmacokinetic/pharmacodynamic relationship for cefazolin has not been evaluated in patients. 12.3 Pharmacokinetics Studies have shown that following intravenous administration of cefazolin to normal…
Indications (17)
respiratory tract infections due to Streptococcus pneumoniaeStaphylococcus aureusStreptococcus pyogenes in adultsurinary tract infections due to Escherichia coliProteus mirabilis in adultsskinskin structure infections due to Sbiliary infections due to Ebonejoint infections due to Sgenital infections due to Esepticemia due to Sendocarditis due to Sthe following infections caused by susceptible isolates of the designated microorganisms in adult(aged 10 to 17 years old) surgical patients in whom infection at the operative site would present a serious risk (eincidence of certain postoperative infections in patients undergoing surgical procedures which are classifiedpotentially contaminated (e